Merckv Wyeth News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Merckv wyeth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Merckv Wyeth Today - Breaking & Trending Today
In the fall of 2021, the Rx IP Update team celebrated its 20thyear of monthly updates on Canadian life sciences IP and regulatory law. Below are highlights from our team’s 2021. ....
Introduction On 30 April 2021 the Federal Court issued a decision on the validity of three patents relating to Pfizer s PREVNAR 13, a 13-valent pneumococcal polysaccharide protein conjugate vaccine ( Merck v Wyeth, 2021 FC 317). Merck had sought to impeach Wyeth s patents – Canadian Patents 2,604,363 (363 Patent) 2,650,056 (056 Patent) and 2,803,111 (111 Patent) – on the basis that it believed that Wyeth (now Pfizer) would assert the patents against its 15-valent pneumococcal polysaccharide protein conjugate vaccine, V114. Merck filed a new drug submission for V114 during trial. The court upheld the validity of the 363 Patent (though construed the claims to be limited to the specified 13 serotypes) but declared the 056 and 111 Patents invalid. ....
Federal Court upholds validity of one pneumococcal vaccine patent, but holds two other patents invalid | Smart & Biggar jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.